Validation of a measure of contraceptive self-injection self-efficacy in Uganda
Sexual and reproductive health self-care interventions, including self-administered injectable contraception, can promote individual agency and health. As an increasing number of programs seek to introduce and expand access to self-injectable contraception, it’s imperative to develop measures that define programmatic success based on whether people have the opportunity to make a decision about self-injectable use with agency, rather than relying on measures of self-injectable uptake. We performed psychometric evaluation to validate a self-injectable self-efficacy scale using cross-sectional survey data collected among 2,369 sexually active, reproductive aged women in Uganda. We examined descriptive statistics of a pool of five potential items before conducting an Exploratory Factor Analysis to determine factor structure and reduce the item pool. We ran a Confirmatory Factor Analysis to confirm the factor structure and performed a correlation analysis to determine whether the final self-injectable self-efficacy scale was correlated with items related to contraceptive decision-making self-efficacy and previous self-injectable use. Our final measure of self-injectable self-efficacy is a unidimensional scale that contains three items: 1) “I feel confident that I could self-inject on my own at the end of training,” 2) “I feel confident that I can do all the steps correctly and will be protected from pregnancy,” and 3) “I can manage to self-inject even if I feel very scared at first.” Self-injectable self-efficacy was positively and significantly correlated with prior self-injectable use and items related to contraceptive decision-making self-efficacy. We validated a novel self-care focused measure of self-injectable self-efficacy in Uganda. Self-injectable self-efficacy, which can be measured among all reproductive-aged women regardless of prior self-injectable training or use, can be used to evaluate self-injectable programs to determine whether programs equip people with the tools needed to successfully use self-injectable contraception if they desire.
Authors
- Brooke W. Bullington (ORCID: https://orcid.org/0000-0002-3341-087X)
- Sneha Challa (ORCID: https://orcid.org/0000-0001-5220-6834)
- Catherine Birabwa (ORCID: https://orcid.org/0000-0003-2916-9275)
- Dinah Amongin (ORCID: https://orcid.org/0000-0002-1420-005X)
- Jane Cover (ORCID: https://orcid.org/0000-0002-9547-4190)
- Peter Waiswa (ORCID: https://orcid.org/0000-0001-9868-0515)
- Kelsey Holt (ORCID: https://orcid.org/0000-0001-9093-4322)
- Ronald Wasswa (ORCID: https://orcid.org/0000-0003-1251-2460)
- Sylvia Nanono
Institutions
- Program for Appropriate Technology in Health (US)
- University of California, San Francisco (US)
- University of Utah (US)
- University of Utah Hospital (US)
- Institute on Aging (US)
- Makerere University (UG)
Publication Details
- Journal
- BMC Women s Health
- Published
- 2025-09-22
- DOI
- https://doi.org/10.1186/s12905-025-03982-y
- Primary Topic
- Reproductive Health and Contraception
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bill and Melinda Gates Foundation
- National Institutes of Health
- University of North Carolina at Chapel Hill
- Carolina Population Center, University of North Carolina at Chapel Hill